Brown TD - Search Results

1

Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group study.

Kuebler JP, Goodman PJ, Brown TD, Crawford ED, Reitz CL, Knight WA 3rd, Kish JA. Kuebler JP, et al. Among authors: brown td. Invest New Drugs. 1990 Aug;8(3):307-9. doi: 10.1007/BF00171843. Invest New Drugs. 1990. PMID: 2125585 Clinical Trial. No abstract available.

2

Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.

Brown TD, Goodman PJ, Fleming TR, Baker LH, Macdonald JS. Brown TD, et al. Invest New Drugs. 1991 Feb;9(1):77-8. doi: 10.1007/BF00194550. Invest New Drugs. 1991. PMID: 1827433 Clinical Trial. No abstract available.

3

Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group study.

Brown TD, Goodman PJ, Fleming TR, Taylor SA, Macdonald JS. Brown TD, et al. Invest New Drugs. 1991 Feb;9(1):113-4. doi: 10.1007/BF00194561. Invest New Drugs. 1991. PMID: 2026480 Clinical Trial. No abstract available.

4

Phase II trial of recombinant DNA gamma-interferon in advanced colorectal cancer: a Southwest Oncology Group study.

Brown TD, Goodman PJ, Fleming T, Macdonald JS, O'Rourke T, Taylor SA, Neefe JR, Gaynor E. Brown TD, et al. J Immunother (1991). 1991 Oct;10(5):379-82. doi: 10.1097/00002371-199110000-00011. J Immunother (1991). 1991. PMID: 1790147 Clinical Trial.

5

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

Von Hoff DD, Fleming TR, Macdonald JS, Goodman PJ, Van Damme J, Brown TD, O'Rourke T, Feun LG, Keppen MD. Von Hoff DD, et al. Among authors: brown td. J Biol Response Mod. 1990 Dec;9(6):584-7. J Biol Response Mod. 1990. PMID: 2127424 Clinical Trial.

6

A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: a Southwest Oncology Group study.

Brown TD, Goodman P, Fleming T, Macdonald JS, Hersh EM, Braun TJ. Brown TD, et al. J Immunother (1991). 1991 Oct;10(5):376-8. doi: 10.1097/00002371-199110000-00010. J Immunother (1991). 1991. PMID: 1790146 Clinical Trial.

7

A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancer: a Southwest Oncology Group study.

Brown TD, Fleming TR, Goodman PJ, Macdonald JS, Pugh RP, O'Rourke T. Brown TD, et al. Anticancer Drugs. 1995 Apr;6(2):219-23. doi: 10.1097/00001813-199504000-00004. Anticancer Drugs. 1995. PMID: 7795270 Clinical Trial.

8

Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study.

Brown TD, Goodman PJ, Fleming T, Macdonald JS, Craig JB, Einstein AB. Brown TD, et al. Anticancer Drugs. 1993 Feb;4(1):49-50. doi: 10.1097/00001813-199302000-00006. Anticancer Drugs. 1993. PMID: 8457714 Clinical Trial.

9

High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers.

Muggia FM, Brown TD, Goodman PJ, Macdonald JS, Hersh EM, Fleming TR, Leichman L. Muggia FM, et al. Among authors: brown td. Anticancer Drugs. 1992 Jun;3(3):211-7. doi: 10.1097/00001813-199206000-00002. Anticancer Drugs. 1992. PMID: 1525400 Clinical Trial.

10

Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience.

Hersh EM, Metch BS, Muggia FM, Brown TD, Whitehead RP, Budd GT, Rinehart JJ, Crawford ED, Bonnet JD, Behrens BC. Hersh EM, et al. Among authors: brown td. J Immunother (1991). 1991 Dec;10(6):426-31. doi: 10.1097/00002371-199112000-00006. J Immunother (1991). 1991. PMID: 1768676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters